Hype? 3 Phase 3 trials? That's 3b min in outlay to get there. Find me another biotech this far progressed that's so cheap. It's becoming increasingly obvious why you remained a Gp.
- Forums
- ASX - By Stock
- MSB
- 2023 The Final Countdown
2023 The Final Countdown, page-2105
-
- There are more pages in this discussion • 1,299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.035(2.94%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $5.183M | 4.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 191274 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 46965 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
46 | 74867 | 1.160 |
22 | 94361 | 1.155 |
19 | 230762 | 1.150 |
13 | 204738 | 1.145 |
8 | 197138 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 131523 | 18 |
1.170 | 119729 | 17 |
1.175 | 61191 | 10 |
1.180 | 77792 | 10 |
1.185 | 36343 | 4 |
Last trade - 15.15pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online